Association between spironolactone use and COVID-19 outcomes in population-scale claims data: a retrospective cohort study

BACKGROUND: Spironolactone has been proposed as a potential modulator of SARS-CoV-2 cellular entry. We aimed to measure the effect of spironolactone use on the risk of adverse outcomes following COVID-19 hospitalization. METHODS: We performed a retrospective cohort study of COVID-19 outcomes for pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Cousins, Henry C., Altman, Russ B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002773/
https://www.ncbi.nlm.nih.gov/pubmed/36909470
http://dx.doi.org/10.1101/2023.02.28.23286515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002773/
https://www.ncbi.nlm.nih.gov/pubmed/36909470
http://dx.doi.org/10.1101/2023.02.28.23286515

Ejemplares similares